Article Sidebar

Submitted
Apr 21, 2021
Published
Apr 21, 2021
Download
PDF
Statistic
Read Counter : 81 Download : 81

Main Article Content

Abstract

DDS-Drug delivery systems are getting progressively modern as pharma scientists acquires a clearer insight of the physico-biochemical boundaries appropriate to their performance. In the last four decades, orally dissolving/disintegrating tablets(ODTs) have acquired significant consideration as a desirable alternate option because of improved patient compliance in contrast to conventional capsules and tablets. ODTs are solid dosage forms containing therapeutic ingredients that disintegrate rapidly within seconds in the oral cavity leaving an easy to swallow residue. orally dissolving/disintegrating tablets advancements addressing numerous medicine and patient necessities, varying from improved life cycle management to appropriate administer dose of medicine for pediatric, mental and geriatric patients with dysphagia. The main object of the present review was centered on to explain the evolution, processing technology, formulation attributes, evaluation parameters, advantages, limitations and global market status of ODT’s and future potential prospects

Keywords

Drug delivery systems (DDS) Orally disintegrating tablets(ODTs) Current research

Article Details

How to Cite
V.T.Iswariya, & Annamma Devi.G.S. (2021). A review on oral disintegrating tablets: aboon in the world of pharmaceuticals. International Journal of Research in Pharmacology & Pharmacotherapeutics, 10(1), 97-106. https://doi.org/10.61096/ijrpp.v10.iss1.2021.97-106
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Kantharao CH, Swarna K, Leelakrishna J, Anusha J, Asha B, et al. (2019) Diclofenac Orodispersible Tablets: Formulation and In Vitro Evaluation. Ann Clin Lab Res Vol.7 No.1: 287.
  2. [2]. Lindgren S, Janzon L. (1993) Dysphagia; Prevalence of swallowing complaints and clinical findings. Medical clinics of North America., 77: 3-5.
  3. [3]. Notenboom, Beers,Diana, et al. (2014) Practical Problems with Medication Use that Older People Experience: A Qualitative Study. JAGS. Vol.62, NO:12.
  4. [4]. Shabana. Md (2016) A Review on the Quality Control Analysis of Oral Dosage Form: Tablets: RRJPPS., Volume 5 Issue: 2.
  5. [5]. Fu Y, Yang S, Jeong SH, Kimura S, Park K. (2004) orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies. Critical Review in Therapeutic Drug Carrier System., 21:433-76.
  6. [6]. Makino T, Yamada M. and Kikuta, J. (1993) Fast dissolving tablet and its production, European Patent. 0553777 A2.
  7. [7]. Seager H. (1998) Drug-deliver products and the zydis fast-dissolving dosage form. Journal of Pharmacy and Pharmacology. 50: 375-382.
  8. [8]. Van Scoik KG. Solid pharmaceutical dosage in tablet triturates form and method of producing the same. US patent. 5, 082, 667
  9. [9]. Cirri M, Valleri M, Mura P, Maestrelli F and Ballerini R. Development of fast dissolving tablets offlurbiprofencyclodextrin complexes. Drug Development and Industrial Pharmacy. 2005; 31(7): 697- 707.
  10. [10]. Gohel M, Patel M, Agarwal R and Dev R. Formulation Design and Optimization of Mouth Dissolve Tablets of Nimesulide Using Vacuum Drying Technique AAPS Pharm Sci Tech. 3, 2004, 36.
  11. [11]. Kaushik D, Dureja H and Saini TR. Orally disintegrating tablets: An overview of melt in mouth tablet technologies and techniques, Tablets, Capsules, 2004; 2: 30-36
  12. [12]. Bangale SG, Shinde GV, Rathinaraj BS. New generation oforodispersible tablets: recent Journal of Advances in Pharmaceutical Sciences 2011;2(3):17-28ORAL DISINTEGRATING TABLETS: A BOON IN THE WORLD OF PHARMACEUTCALS
  13. [13]. Jesmeen T, Uddin R. Orodispersible tablets: A short review. Stamford Journal of Pharmaceutical Sciences 2011;4(1):96-99
  14. [14]. GafiţanuE, Dumistracel I, Antochi S. Formulations and bioavailability ofpropyphenazone in lyophilized tablets. Revista Medico-chirurgicala a Societatii De Medici Si Naturalisti Din Iasi 1991;95(1-2):127-128
  15. [15]. Arnum PV. An Orally disintegrating tablets (ODTs) continue to attract attention as an alternative to the conventional oral dosage forms. Pharm Tech AdvDev Manu, 2007, 1-4
  16. [16]. Gittings S, Turnbull N, Roberts CJ, Gershkovich P. The Dissolution methodology for the taste masked oral dosage forms. J Contol Release. 2014; 173:32-42
  17. [17]. Bhandari S, Kumar R, MittapalliR, Madhusudan R. The Oro-dispersible tablet: An overview. As J Pharma. 2008; 2:2‐11
  18. [18]. Biradar SS, Bhagavati ST, Kuppasad IJ. A brief overview on Fast dissolving drug delivery systems, Int J Pharmacol. 2006; 4:90-2.
  19. [19]. Pahwa R, Piplani M, Sharma PC, Kaushik D, Nanda S. Orally disintegrating tablets-friendly to pediatrics and geriatrics. Archives of Applied Science Research 2010;2(2):35-48.
  20. [20]. Agarval VA, Rajkumar RM, Ingale RG. Fast disintegrating tablet as new drug delivery system: A review. Pharmacophore 2011;2(1):81-88
  21. [21]. Kumari R, Chandel P, Kapoor A. Fast dissolving tablets: needs to enhance bioavailability. International Research Journal of Pharmacy 2013;4(5):51-58
  22. [22]. Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. Journal of Pharmacy and Pharmacology. 1998; 50(4):375-82.
  23. [23]. Makino T, Yamada M. and Kikuta, J. Fast dissolving tablet and its production, 1993, European Patent. 0553777 A2
  24. [24]. Brown D. Orally Disintegrating Tablets Taste over Speed. Drug Delivery Technology. 2003; 3:58-61.
  25. [25]. Dobetti L. Fast Melting Tablets: Development and Technologies. Pharmaceutical Technology. 2001; 44- 50
  26. [26]. Ahmed IS, Nafadi MM and Fatahalla FA, Formulation of a fast-dissolving ketoprofen tablet using freeze- drying in blisters Review Article www.ijcps.com 12 technique. Drug Development and Industrial Pharmacy. 2006; 32(4): 437- 42
  27. [27]. Modi A and Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS Pharm. Sci. Tech., 2006; 7(3): 68-75
  28. [28]. Douroumis DD, Gryczke A, Schminke S. Development and evaluation of cetirizine hcltastemasked oral disintegrating tablets. American Association of Pharmaceutical Scientists PharmSciTech 2011;12(1):141-151
  29. [29]. Konapure SA, Chaudhari PS, Oswal RJ, Kshirsagar SS, Antre RV, Chorage TV. Mouthdissolving tablets an innovative technology. International Journal of Applied Biology and Pharmaceutical Technology 2011;2(1):496-503
  30. [30]. Shukla D, Chakarborty S. Mouth dissolving tablets: An overview of formulation technology. Scientia Pharmaceutica 2009;77 (2):309-326ORAL DISINTEGRATING TABLETS: A BOON IN THE WORLD OF PHARMACEUTCALS
  31. [31]. Vani R, Rasheed A. Formulation and evaluation of hydrochlorothiazide and ramipril mouth dissolving tablet using different superdisintegrants. International Journal of Pharma Sciences and Research 2014;5(1):207-212
  32. [32]. Thakur RR, Narwal S. Orally disintegrating preparations: recent advancement in formulation and technology. Journal of Drug Delivery and Therapeutics 2012;2(3):87-96
  33. [33]. Panigrahi D, Baghel S and Mishra B, Mouth dissolving tablets: An overview of preparation techniques, Evaluation and Patented technologies. J Pharm Research. 2005; 4(3): 33-41
  34. [34]. Shailesh Sharma. New generation of tablet: Fast dissolving tablet. Pharmainfo.net. 2008; 6 (1): 111-119.
  35. [35]. Jain D, Amul M. A Review on Formulation & Development of Oro-dispersible Tablets, Int J Pharm Eru. 2014; 4:21-38
  36. [36]. Seager H. A Drug‐deliver Product and the Zydis Fast‐ dissolving Dosage Form. J Pharm Pharmacol. 1998; 50:375‐82
  37. [37]. .Bhaskaran S, Narmada GV. The rapid dissolving tablet a novel dosage forms. Indian Pharmacist. 2002; 1:9‐12
  38. [38]. Garcia-Arieta A, Gordon J. BCS biowaivers: Orally disintegrating tablets, Eur J Pharm Sci. 2015; 66:107-8
  39. [39]. Yapar EA. An Overview on Orally Disintegrating Tablets, J App Pharm Sci. 2014; 4:118-25
  40. [40]. Sastry SV, Nyshadham JR, Fix JA. A Review on recent technological advances in the oral drug delivery, Pharm Sci Technolo Today. 2000; 3:138-45.
  41. [41]. Culcu T, Comoglu T. The Fast Disintegrating/Dissolving Tablets, J Fac Pharm Ankara. 2010; 39:69-90. 37. Nayak AK, Manna K. The Current developments in an orally disintegrating tablet technology, J Pharm Edu Res. 2011; 2:21-34
  42. [42]. Aguilar-Diaz JE, Garcia-Montoya E, et al. An application of the new SeDeM-ODT expert system: Predicting an orally disintegrating tablets formulations of ibuprophen tablets, Eur J Pharm Biopharm. 2012; 80:638-48.
  43. [43]. Kaur T, Gill B, Kumar S, Gupta GD. A Novel Approach to Drug Delivery on Mouth Dissolving Tablets, Int J Curr Pharm Res. 2011; 3:1-7
  44. [44]. Nagar P, Singh K, et al. Formulation, preparation techniques and evaluation of Orally disintegrating tablets, J Appl Pharm Sci. 2011; 1:35-45
  45. [45]. Kumar SV, Gavaskar B, Sharan G, Rao YM. An Overview on fast dissolving films, Int J Pharmacy Pharm Sci. 2010; 2:29-33. 9. Committee for the Medicinal Products of Human Use, European Medicines Agency EMEA: A Reflection paper: the formulation of choice for the pediatric population, 2006.
  46. [46]. DobettiL. A Fast‐Melting Tablets: Developments and Technologies: The Pharmaceutical Technology. Drug Delivery (Supplement), 2001, 44‐50
  47. [47]. Devrajan PV, Gore SP. An innovative oral drug delivery system on Melt‐in‐mouth tablets, Express Pharma Pulse. 2000; 7:16-18.
  48. [48]. Wehling F, Schuehle S, Madamala N. Effervescent dosage form with microparticles. US Patent. 1993
  49. [49]. Robertson MI. The Regulatory Issues with Excipients. Int J Pharm. 1999; 187:273-6ORAL DISINTEGRATING TABLETS: A BOON IN THE WORLD OF PHARMACEUTCALS
  50. [50]. Kumare MM, Marathe RP, Kawade RM, Ghante MH, Shendarkar GR. Design of fast dissolving tablet of atenolol using novel co-processed superdisintegrant. Asian Journal of Pharmaceutical and Clinical Research 2013;6 (3):81-85
  51. [51]. MohanachandranPS, Sindhumol PG, Kiran TS. Superdisintegrants: An overview. International Journal of Pharmaceutical Sciences Review and Research 2011;6(1): 105-109.
  52. [52]. Kumar S, Gupta SK, Sharma PK. A Review on the Recent Trends in Oral Drug Delivery/Fast Dissolving Formulation Technology. Adv Biol Res. 2012; 6:6-13.
  53. [53]. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); Guidance for the Industry on Orally Disintegrating Tablets – CDER Data Standards Manual, Chemistry, 2008, 1-3
  54. [54]. Ganesh NS, Deshpande KB. An Overview of Formulation and Technology of Orodispersible tablets, Int J Pharma Bio Sci. 2011; 2:726-34
  55. [55]. Kizumi K, Watanabe Y, Morita K, Utoguchi N and Matsumoto M, New method of preparing highporosity rapidly saliva soluble compressed tablets using mannitol with camphor: sublimating material. Internatinal Journal of Pharmaceutics, 1997; 152: 127-31 A
  56. [56]. Kawano Y, Ito A, Sasatsu M, Machida Y. Preparation of orally disintegrating tablets with tastemasking function: masking effect in granules prepared with correctives using the drygranulation method and evaluation of tablets prepared using the taste-masked granules. YakugakuZasshi 2010;130(1):81-86.
  57. [57]. Siden R, Wolf M. Disintegration of chemotherapy tablets for oral administration in patients with swallowing difficulties. Journalof Oncology Pharmacy Practice2013;19(2):145-150
  58. [58]. A.N. Zaid et al. Weight and content uniformity of lorazepam half-tablets: A study of correlation of a low drug content product Saudi Pharmaceutical Journal (2013) 21, 71–75
  59. [59]. Mizumoto T, Masuda Y, Fukui M. Intrabuccally dissolving compressed moldings and production process thereof. US Patent. 1996
  60. [60]. Fu Y, Yang S, Jeong SH, Kimura S, Parket K. Orally fast disintegrating tablets: developments, technologies, taste masking and clinical studies. Critical Reviews in Therapeutic Drug Carrier Systems 2004;21 (6):433-475.